The Vanguard Group 13D and 13G filings for Corcept Therapeutics Incorporated:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:02 pm Sale |
2023-12-29 | 13G | Corcept Therapeutics Incorporated CORT |
The Vanguard Group | 9,537,532 9.250% |
-807,498 (-7.81%) |
Filing |
| 2023-02-09 11:15 am Sale |
2022-12-30 | 13G | Corcept Therapeutics Incorporated CORT |
The Vanguard Group | 10,345,030 9.610% |
-499,759 (-4.61%) |
Filing |
| 2022-03-09 08:44 am Purchase |
2022-02-28 | 13G | Corcept Therapeutics Incorporated CORT |
The Vanguard Group | 10,844,789 10.230% |
47,312 (+0.44%) |
Filing |
| 2022-02-09 3:43 pm Sale |
2021-12-31 | 13G | Corcept Therapeutics Incorporated CORT |
The Vanguard Group | 10,797,477 9.350% |
-1,198,672 (-9.99%) |
Filing |
| 2021-02-10 10:46 am Purchase |
2020-12-31 | 13G | Corcept Therapeutics Incorporated CORT |
The Vanguard Group | 11,996,149 10.330% |
264,345 (+2.25%) |
Filing |
| 2020-10-13 11:04 am Purchase |
2020-09-30 | 13G | Corcept Therapeutics Incorporated CORT |
The Vanguard Group | 11,731,804 10.150% |
783,058 (+7.15%) |
Filing |